PharmAthene

United States · 39 Employees
PharmAthene, Inc. (NYSE MKT: PIP), formed in March 2001, is pursuing its mission to advance the Nation's health security by developing novel medical solutions that utilize cutting-edge biotechnology to offer improvements in safety, efficacy and cost-effectiveness over current therapies. \\The Company's strategy focuses on acquiring and developing new, best-in-class products and technologies identified by the United States and other governments as urgent procurement priorities. Since its inception in 2001, PharmAthene has obtained non-dilutive U.S. government funding commitments in excess of $600 million for the development of its portfolio products.\\PharmAthene's portfolio currently includes the following product candidates:\\ • SparVax® - a next generation recombinant protective antigen (rPA) anthrax vaccine\\ • Recombinant BChE - a novel bioscavenger for the prevention and treatment of morbidity and mortality associated with exposure to chemical nerve agents\\ • Valortim® - a fully human monoclonal antibody for the prevention and treatment of anthrax infection

概述

国家 United States
成立时间 2001
总部 Annapolis, MD
电话号码
网站
LinkedIn http://www.linkedin.com/company/pharmathene
Twitter
Facebook
员工数 39
行业 biotechnology,
简介 PharmAthene, Inc. (NYSE MKT: PIP), formed in March 2001, is pursuing its mission to advance the Nation's health security by developing novel medical solutions that utilize cutting-edge biotechnology to offer improvements in safety, efficacy and cost-effectiveness over current therapies. \\The Company's strategy focuses on acquiring and developing new, best-in-class products and technologies identified by the United States and other governments as urgent procurement priorities. Since its inception in 2001, PharmAthene has obtained non-dilutive U.S. government funding commitments in excess of $600 million for the development of its portfolio products.\\PharmAthene's portfolio currently includes the following product candidates:\\ • SparVax® - a next generation recombinant protective antigen (rPA) anthrax vaccine\\ • Recombinant BChE - a novel bioscavenger for the prevention and treatment of morbidity and mortality associated with exposure to chemical nerve agents\\ • Valortim® - a fully human monoclonal antibody for the prevention and treatment of anthrax infection

技术

Adobe Marketing Cloud

Search Marketing

Amazon AWS

Hosting

DNS Made Easy

Domain Name Services

DigitalOcean

Hosting

Drupal

CMS

Google Font API

Fonts

Google Tag Manager

Tag Management

Mobile Friendly

Other

New Relic

Web Performance Monitoring

Nginx

Load Balancers

Outlook

Email Providers

WordPress.org

CMS

reCAPTCHA

Captcha

常见问题

PharmAthene 在哪里?

PharmAthene 的总部位于 Annapolis, MD

PharmAthene 的电话号码是多少?

PharmAthene 的电话号码是

PharmAthene 的官方网站是什么?

PharmAthene 的公司官方网站是

PharmAthene 是做什么的?

PharmAthene 的业务有哪些?

government contracting,biodefense,biotechnology,vaccine development

PharmAthene 的年收入是多少?

PharmAthene 的收入是 0美元

PharmAthene 有多少员工?

PharmAthene 有 39 名员工

PharmAthene 属于哪个行业?

PharmAthene 从事以下行业: biotechnology

PharmAthene 使用什么技术?

PharmAthene 使用的一些流行技术包括: Adobe Marketing Cloud,Amazon AWS,DNS Made Easy,DigitalOcean,Drupal,Google Font API,Google Tag Manager,Mobile Friendly,New Relic,Nginx,Outlook,WordPress.org,reCAPTCHA

如何联系 PharmAthene?

PharmAthene 联系信息: 电话号码:, 网站:, 邮箱:ema***@***.com

PharmAthene 的社交媒体链接是什么?

PharmAthene 领英:http://www.linkedin.com/company/pharmathene,fackbook:,twitte:

PharmAthene 是一家上市公司吗?

不是

PharmAthene 的最后一轮融资是什么时候?

暂无最近投资信息

谁投资 PharmAthene?

PharmAthene 有 0 家投资者,包括 。

管理层

Timothy Roesing

Past VP of Manufacturing, Supply, Process Sciences

Howard Seligsohn

Director, Analytical Sciences RTP

Joyce Addis

Quality Documentation Supervisor

Matthew Meldorf

Senior Program Director

Mark Bolanowski

Senior Program Director

外贸获客 查找关键决策人

10亿+海关交易数据,1.2亿企业数据,2亿+企业联系人数据,1000千万真实采购商。覆盖200+个国家及地区,95%外贸重点拓展市场,可根据行业、经营范围等多方位挖掘目标客户。
免费试用

Top-ranked on G2 Crowd

全球B2B企业库 海关贸易数据 展会采购数据

工作更少,成就更大,销售更聪明

查找更多 B2B 联系人,丰富并验证记录
Email Address

全球B2B企业库

海关贸易数据

展会采购数据

Top-ranked on G2 Crowd

OR
Sign Up with Google